Checkpoint NOW
By Afreen Shariff
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Afreen Shariff
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 33
Description
All you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.
| Episode | Date |
|---|---|
|
Episode 32: Type 1 Diabetes from Immune Checkpoint Inhibitors: What patients and caregivers need to know
|
Jun 02, 2026 |
|
Episode 31: Journal Club: To re-challenge or not in refractory pneumonitis
|
Jun 05, 2025 |
|
Episode 30: Fatigue and Cancer- Symptom of cancer or a sign of a toxicity?
|
May 09, 2025 |
|
Episode 29: Balancing conversations about toxicities
|
Nov 12, 2024 |
|
Episode 28: Alliance Clinical Trial for Immune Mediated toxicities
|
Oct 07, 2024 |
|
Episode 27: ASPirE- The International Alliance for Support and Prevention of immune related Events
|
Aug 19, 2024 |
|
Episode 26: Cancer treatments and the Heart
|
Aug 13, 2024 |
|
Episode 25: Adrenal Insufficiency- What patients need to know.
|
Jul 07, 2024 |
|
Episode 24: Costs of adverse events in Renal Cell Carcinoma
|
Oct 23, 2023 |
|
Episode 23: Emotional impact of side effects on patients and caregivers
|
May 17, 2023 |
|
Episode 22: Germline Variants, Toxicities and ICI
|
Apr 13, 2023 |
|
Episode 21: Thyroid disease in cancer patients. What you need to know as a patient!
|
Nov 27, 2022 |
|
Episode 20: Patient experience, advocacy and immune toxicities
|
Sep 26, 2022 |
|
Episode 19: ICI use in Special Populations
|
Feb 08, 2022 |
|
Episode 18: Immune mediated neurological toxicities (Part 2)
|
Dec 19, 2021 |
|
Episode 17: Autoimmune Type 1 Diabetes: Challenge for our patients and clinicians
|
Nov 17, 2021 |
|
Episode 16: Learning about Immune mediated Adverse events from a trainees persepective
|
Sep 21, 2021 |
|
Episode 15: Neuro-toxicities from Immune checkpoint Blockade: Rare and complex (Part 1)
|
Jul 13, 2021 |
|
Episode 14: Immune Mediated Liver Injury
|
Jun 17, 2021 |
|
Episode 13: Skin Toxicities from Immune Checkpoint Inhibitors (PART 2): Common and perplexing
|
May 26, 2021 |
|
Episode 12: Skin Toxicities from Immune Checkpoint Inhibitors (PART 1): Common and perplexing
|
May 03, 2021 |
|
Episode 11: Onco-Nephrology and Immune Mediated Nephrotoxicities
|
Apr 12, 2021 |
|
Episode 10: Immune Mediated Pulmonary Toxicities
|
Mar 30, 2021 |
|
Episode 9: Immune Mediated Cardiac Toxicities: Diagnostic challenges, management and novel discoveries.
|
Mar 16, 2021 |
|
Episode 8: Immune Mediated Colitis- Novel discoveries and novel therapies
|
Mar 03, 2021 |
|
Episode 7: Immune Mediated Colitis and lessons learnt from multidisciplinary team based management.
|
Feb 16, 2021 |
|
Episode 6: Rheumatic adverse events: Discussions on biomarkers, collaborations and more.
|
Feb 01, 2021 |
|
Episode 5: Immune mediated Myositis and Myalgia's: Diagnosis & management for the non-Rheumatologist
|
Jan 18, 2021 |
|
Episode 4: Immune mediated Inflammatory Arthritis: Challenges in diagnosis and management
|
Jan 05, 2021 |
|
Episode 3: Breaking down the diagnosis and management of Immune Hypophysitis
|
Dec 08, 2020 |
|
Episode 2: Immune Related Thyroid Toxicities
|
Dec 01, 2020 |
|
Episode 1: Immune Checkpoint Inhibitors have been transformative for cancer care. What have we learnt so far?
|
Nov 24, 2020 |
|
Checkpoint NOW
|
Aug 17, 2020 |